United States · Series C startup

Who invested in Umoja Biopharma

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$100Mraised across 1 round since 2025, from 1 source

Latest round
Series C, $100MJan 2025
Investors
7
See who backed them

The rounds

  1. Jan 2025

Founders and team

From Umoja Biopharma's own website and the SEC filings it signed: 5 on the team.

  • Nate HardyChief Financial Officer
  • Sally M. DyerSVP, General Manager, Colorado Operations
  • Scott MyersChairman of the Board
  • Andrew M. ScharenbergExecutive Officer, Directori
  • Irena M. MelnikovaExecutive Officeri

On the board, as filediAnna S. FrenchJohn S. HamerLuke S. EvninPhilip S. LowRobert S. Glassman

Everyone who backed them

DCVCVC firm1round
Temasek HoldingsVC firm1round
SoftBankInvestment firm1round
Cormorant Asset ManagementPrivate equity1round
Casdin CapitalVC firm1round
RTW Investments LLCGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 6 firms list Umoja Biopharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

MPM CapitalPrivate equityPer its own site
Presight CapitalVC firmPer its own site
Double Point VenturesVC firmPer its own site
K2 HealthVenturesPrivate equityPer its own site
Myeloma Investment FundCorporate VCPer its own site
Realm Capital VenturesVC firmPer its own site

Quick answers about Umoja Biopharma

Who invested in Umoja Biopharma?

Umoja Biopharma's investors include DCVC, Temasek Holdings, SoftBank, SoftBank Vision Fund and Cormorant Asset Management, and 2 more on record.

How much has Umoja Biopharma raised?

Umoja Biopharma has raised $100M across 1 round since 2025.

When did Umoja Biopharma last raise?

Umoja Biopharma's most recent round was a Series C of $100M in Jan 2025.

What was Umoja Biopharma's biggest round?

Its most recent round, $100M in Jan 2025, is also its largest on record.

Who backed Umoja Biopharma first?

Umoja Biopharma's first round on record, in Jan 2025, was backed by DCVC, Temasek Holdings and SoftBank and 4 others.

What stage is Umoja Biopharma at?

Umoja Biopharma's latest named round is a Series C, in Jan 2025.

Where is Umoja Biopharma based?

Umoja Biopharma is based in the United States.

Companies like Umoja Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.